Avillion II (AZ)
Revolutionising Pharmaceutical Development
- Headquarters
- London
- Business Model
- B2B
About
Avillion is a London-based drug development company that partners with pharmaceutical and biotechnology companies to co-develop and finance late-stage therapeutics, sharing clinical trial costs and regulatory risk in exchange for milestone and royalty payments. Avillion II (AZ) is Avillion's dedicated co-development vehicle with AstraZeneca, which funded the Phase III program for Airsupra (PT027), a rescue asthma treatment that won US FDA approval, and has since expanded to include the additional BATURA Phase IIIb study.
Summary
Avillion II (AZ) is a Biotech company based in London, United Kingdom.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avillion-ii-az"><img src="https://indexed.vc/api/badge/company/avillion-ii-az" alt="Avillion II (AZ) on Indexed.vc" width="260" height="76" /></a>